Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line

BACKGROUND: The SK-PN-DW cell line was established in 1979 and is commercially available. Despite the use of this cell line as an in vitro model for functional and therapeutic studies of malignant primitive neuroectodermal tumor (PNET), there is a lack of complete information about the genetic alter...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Na, Bao, Wanguo, Zhang, Kaiyu, Lu, Xianglan, Crew, Rebecca, Wang, Xianfu, Liu, Guangming, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498632/
https://www.ncbi.nlm.nih.gov/pubmed/31046733
http://dx.doi.org/10.1186/s12885-019-5625-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498632/
https://www.ncbi.nlm.nih.gov/pubmed/31046733
http://dx.doi.org/10.1186/s12885-019-5625-1

Ejemplares similares